BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
17 results:

  • 1. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
    Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
    Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation.
    Sato S; Nakayama K; Kanno K; Sultana R; Ishikawa M; Ishibashi T; Yamashita H; Kyo S
    Cancer Sci; 2023 Jun; 114(6):2335-2344. PubMed ID: 36843384
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway.
    Zhou L; Li H; Zhang D; Chen L; Dong H; Yuan Y; Wang T
    Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36177903
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-β3 and Wnt/β-Catenin pathways.
    Afrin S; Ali M; El Sabeh M; Yang Q; Al-Hendy A; Borahay MA
    J Cell Mol Med; 2022 Mar; 26(5):1684-1698. PubMed ID: 35118811
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/axin2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical cancer.
    Niu Z; Wang F; Lv S; Lv Y; Liu M; Fu L; Yao Y; Wang L; Lin W; Yuan F
    Mol Cell Biol; 2021 Sep; 41(10):e0011521. PubMed ID: 34309414
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Are developmentally missing teeth a predictive risk marker of malignant diseases in non-syndromic individuals? A systematic review.
    Al-Muzian L; Almuzian M; Mohammed H; Ulhaq A; Keightley AJ
    J Orthod; 2021 Sep; 48(3):221-230. PubMed ID: 33455496
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Using machine learning to create prognostic systems for endometrial cancer.
    Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hu J; Hur C; Hershman DL; Wright JD
    Gynecol Oncol; 2020 Dec; 159(3):744-750. PubMed ID: 33019982
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway.
    Jiang XY; Wang L; Liu ZY; Song WX; Zhou M; Xi L
    J Recept Signal Transduct Res; 2021 Aug; 41(4):371-377. PubMed ID: 32896205
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
    Katoh M
    Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo(b)pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression of Wnt/β-catenin signaling and PI3K/Akt survival pathway.
    Chandra V; Fatima I; Manohar M; Popli P; Sirohi VK; Hussain MK; Hajela K; Sankhwar P; Dwivedi A
    Cell Death Dis; 2014 Aug; 5(8):e1380. PubMed ID: 25144715
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
    Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
    van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD
    Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer.
    Kawaguchi M; Banno K; Yanokura M; Kobayashi Y; Kishimi A; Ogawa S; Kisu I; Nomura H; Hirasawa A; Susumu N; Aoki D
    Int J Oncol; 2009 Nov; 35(5):977-82. PubMed ID: 19787250
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake.
    Kidd EA; Spencer CR; Huettner PC; Siegel BA; Dehdashti F; Rader JS; Grigsby PW
    Cancer; 2009 Aug; 115(15):3548-54. PubMed ID: 19472399
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
    Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
    Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.